Repligen RGEN
NASDAQ RGEN
$181.70 +4.47 (+2.52%)
At close: Oct 2, 2026 · 4:00 PM EDT

Repligen (RGEN) Gains from Sales and Divestitures (2011 - 2026)

Updated

Repligen (RGEN) reported Gains from Sales and Divestitures of $103,000 for Q2 2026.

Analysis

Repligen (RGEN) Gains from Sales and Divestitures (2011 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Repligen's Gains from Sales and Divestitures came in at -$13.66 million; for FY2024, it came in at -$3.6 million.

  • The Q2 2026 figure ranks as the highest quarterly Gains from Sales and Divestitures in data going back to Q3 2014.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 242.18 Bn 221.33 Bn 4.88 Bn
2 Abbott Laboratories 168.71 Bn 139.79 Bn 7.27 Bn
3 Danaher 150.46 Bn 134.27 Bn 3.61 Bn
4 Intuitive Surgical 138.71 Bn 118.26 Bn 1.96 Bn
5 Medtronic 110.54 Bn 76.41 Bn 6.34 Bn
6 Stryker 105.66 Bn 91.78 Bn 4.50 Bn
7 Boston Scientific 61.74 Bn 56.75 Bn 3.85 Bn
8 Edwards Lifesciences 49.09 Bn 33.21 Bn 1.35 Bn
9 Becton Dickinson 48.16 Bn 45.31 Bn 2.32 Bn
10 Repligen 10.25 Bn 7.14 Bn 110.04 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 103,000.00
Mar 31, 2026 -13.76 Mn
Jun 30, 2017 -5,000.00
Mar 31, 2017 -59,000.00
Dec 31, 2016 40,000.00
Sep 30, 2016 1,000.00
Jun 30, 2016 -23,000.00
Mar 31, 2016 -3,000.00
Dec 31, 2014 -32,000.00
Sep 30, 2014 -360.00
Mar 31, 2011 -5,597.00
API Access

Repligen Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=RGEN&period=max&api_key=YOUR_API_KEY